» Articles » PMID: 37414842

The Role of Drug-Coated Balloon in Haemodialysis Arteriovenous Fistula Stenosis Management

Overview
Date 2023 Jul 6
PMID 37414842
Authors
Affiliations
Soon will be listed here.
Abstract

Arteriovenous fistula (AVF) stenosis is a common problem leading to dialysis access dysfunction. The conventional balloon (CB) is the most commonly used device during angioplasty but suffers from poor durability of results due to neointimal hyperplasia-mediated recurrence. The drug-coated balloon (DCB) is an adjunct to balloon angioplasty that reduces neointimal hyperplasia, thereby improving post-angioplasty patency. Despite the heterogeneity of DCB clinical trials to date, the evidence suggests that DCBs of different brands are not necessarily equal, and that patient selection, adequate lesion preparation and proper DCB procedural technique are important to realize the benefit of DCB angioplasty.

Citing Articles

Percutaneous transluminal angioplasty is safe and feasible for reinsertion of tunneled cuffed catheters in the right internal jugular vein.

Wang D, Guan Y, Zhuo L, Chen Z, Ma X, Huang Y Sci Rep. 2024; 14(1):24017.

PMID: 39402094 PMC: 11473832. DOI: 10.1038/s41598-024-73154-9.

References
1.
Roy-Chaudhury P, Sukhatme V, Cheung A . Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol. 2006; 17(4):1112-27. DOI: 10.1681/ASN.2005050615. View

2.
Lookstein R, Haruguchi H, Ouriel K, Weinberg I, Lei L, Cihlar S . Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas. N Engl J Med. 2020; 383(8):733-742. DOI: 10.1056/NEJMoa1914617. View

3.
Holden A, Haruguchi H, Suemitsu K, Isogai N, Ross J, Hull J . IN.PACT AV Access Randomized Trial: 12-Month Clinical Results Demonstrating the Sustained Treatment Effect of Drug-Coated Balloons. J Vasc Interv Radiol. 2022; 33(8):884-894.e7. DOI: 10.1016/j.jvir.2022.03.606. View

4.
Irani F, Teo T, Tay K, Yin W, Win H, Gogna A . Hemodialysis Arteriovenous Fistula and Graft Stenoses: Randomized Trial Comparing Drug-eluting Balloon Angioplasty with Conventional Angioplasty. Radiology. 2018; 289(1):238-247. DOI: 10.1148/radiol.2018170806. View

5.
Bjorkman P, Weselius E, Kokkonen T, Rauta V, Alback A, Venermo M . Drug-Coated Versus Plain Balloon Angioplasty In Arteriovenous Fistulas: A Randomized, Controlled Study With 1-Year Follow-Up (The Drecorest Ii-Study). Scand J Surg. 2018; 108(1):61-66. DOI: 10.1177/1457496918798206. View